Kringle Pharma (4884) · InitiativeRestated
Strengthening audit functions by transitioning to a company with an audit and supervisory committee
First written in FY2020. 1 of 2 entries say "Restated". Latest entry: FY2022.
2entries
3years
0from disclosures
How it moved
Same theme, other companies
Strengthening Audit and Oversight Functions through a Transition to a Company with a Board of Corporate AuditorsA theme 3 companies write about · 0 as a headwind · 3 as a tailwind
1 other company's latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
- FY2022RestatedAnnual report
「We determined that transitioning from a company with an audit & supervisory officer to a company with an audit & supervisory board would enable us to respond to the diversification of our business and further strengthen our corporate governance.」
監査役会設置会社への移行による牽制機能・監査機能の強化を引き続き説明している。 - FY2020First statedAnnual report
「We determined that transitioning from a company with an audit & supervisory officer to a company with an audit & supervisory board would enable us to respond to the diversification of our business and further strengthen our corporate governance.」
The company transitioned to a company with an audit & supervisory board in December 2018, adopting a structure that separates business execution from auditing and strengthens checks and balances.